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Abstract
Cardiac papillary fibroelastomas (CPFs) are the second 
most common primary cardiac tumors and the most 
common cardiac valvular tumors. Although they are 
histologically benign and usually asymptomatic, CPFs 
can lead to serious and life-threatening complications 
like myocardial infarction, stroke, pulmonary embolus, 
cardiac arrest etc. CPFs represent a rare entity in clinical 
medicine and literature regarding their management 
is limited. We report two cases which illustrate such com-
plications arising from undiagnosed CPFs on the aortic 
valve. We further stress on the importance of identifying 
CPFs early so that they can be managed appropriately 
based on recommendations from the available literature.
Key words: Lambl’s excrescences; Aortic valve; Cardiac 
tumors; Cardiac papillary fibroelastoma; Sudden cardiac 
death
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Core tip: The cases illustrate serious complications 
that can arise from an undiagnosed cardiac papillary 
fibroelastoma. The importance of continued investigation 
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with a transesophageal echo when there is high clinical 
suspicion is explained. Current management strategies 
have been outlined based on available literature.
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INTRODUCTION
Primary cardiac tumors are rare and have a very low 
prevalence of based on 22 large autopsy studies[1]. 
Cardiac papillary fibroelastomas (CPFs) are the second 
common primary cardiac tumors[2]. For decades, CPFs 
were thought to be asymptomatic and incidental autopsy 
findings. However, in the past two decades they have 
gained importance as they have the potential to cause 
fatal and life-threatening complications. They represent 
a rare entity in clinical medicine and literature regarding 
their management is limited. We report two cases of 
CPFs presenting with cardiovascular and neurological 
complications and outline the importance of having a 




A 64-year-old man was transferred to our institution for 
further management of congestive heart failure, acute 
kidney injury and lower gastrointestinal bleeding. He 
initially presented to the other institution with worsening 
dyspnea and orthopnea. His medical history was sig-
nificant for hypertension, congestive heart failure, and 
non-ST elevation myocardial infarction (NSTEMI). Prior 
coronary angiography was significant for non-obstructive 
coronary artery disease (CAD). At the other institution, 
a chest roentgenogram showed moderately large right-
sided effusion. Transthoracic echocardiography (TTE) 
showed moderately reduced left ventricular systolic func-
tion with an ejection fraction of 35%-40% and severely 
reduced right ventricular systolic function. A diagnosis 
of acute decompensated heart failure was made and 
he was started on intravenous furosemide. Hospital 
course was complicated by acute kidney injury and lower 
gastrointestinal bleeding. The patient refused blood 
product transfusion as he was a Jehovah’s Witness. He 
did not improve clinically and was transferred to our 
institution. At the time of transfer to our institution, his 
hemoglobin was 6.3 g/dL and blood pressure was 90/40 
mmHg. In our institution, ECG did not reveal ischemic 
changes, troponin Ⅰ was elevated at 1.10 ng/mL, and brain 
natriuretic peptide level was elevated at 533 pg/mL. 
He was admitted to the medical intensive care unit for 
further management. Approximately 4 h after admission 
he developed severe hypotension which rapidly progressed 
to cardiac arrest with asystole. Despite resuscitative mea-
sures, patient expired. 
Autopsy showed cardiomegaly (750 g), old inferior wall 
infarct and healing acute right ventricular myocardial 
infarct. There was a large bulky tan-white non-en-
capsulated, rubbery, firm lesion with short pedicle and 
multiple papillary fronds on the aortic valve measuring 
1.5 cm × 1.0 cm in size, completely occluding the right 
coronary ostium (Figure 1). Histological section of the 
mass shows benign papillary lesion comprised of a 
single layer of endocardial cells overlies a thin layer 
of mucopolysaccharide matrix and underlying, almost 
acellular, avascular stroma composed predominantly 
of elastic fibers. Elastin stain reveals concentric elastin 
fibres within the papillary excrescences (Figure 2). Imm-
unohistochemical stains reveal lining endothelial cells 
are positive for S100, CD34 and Factor Ⅷ. Coronary 
artery atherosclerosis of the left anterior descending 
artery (10%-20% occlusion), the left circumflex artery 
(10%-20%), and the right coronary artery (20%-30% 
occlusion) was seen. Coronary emboli were not noted. 
Based on the autopsy findings, the immediate cause 
of death was acute myocardial infarction secondary to 
papillary giant fibroelastoma of aortic valve completely 
occluding the right coronary ostium.
Case 2
A 53-year-old female with a history of diabetes mellitus 
and NSTEMI presented with sudden onset tingling and 
numbness on her left side of her face, mouth, upper and 
lower extremities. Symptoms resolved spontaneously 
in one hour with no sequelae. Computed tomography 
(CT) scan of the head and CT angiography of cerebral 
and carotid arteries were unremarkable. Magnetic reso-
nance imaging of the brain did not show signs of acute 
infarction. Based on these findings, she was diagnosed 
Weight: 750 g
1.5 cm × 1.0 cm
Figure 1  Autopsy specimen of the heart demonstrating a cardiac papillary 
fibroelastoma on the aortic valve. Note the large bulky tan-white non-
encapsulated, rubbery, firm lesion with short pedicle and multiple papillary 
fronds on the aortic valve measuring 1.5 cm × 1.0 cm in size, completely 
occluding the right coronary ostium (blue circle).
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with a transient ischemic attack (TIA). Further stroke 
workup with a TTE showed a mobile mass on the 
aortic valve (Figure 3) which was later confirmed by 
a transesophageal echocardiography (TEE). A mobile, 
pedunculated, 1.2 cm round mass on the aortic side of 
the non-coronary cusp of a tri-leaflet aortic valve was 
seen in the TEE, with an appearance most consistent 
with a fibroelastoma. She was afebrile and blood cultures 
were negative, ruling out endocarditis. Attributing the TIA 
symptoms to embolization from the fibroelastoma, she 
was referred for surgical removal. Pathological exam of 
the resected mass confirmed a fibroelastoma. She was 
discharged and remained symptom free.
DISCUSSION
The first case illustrates a fatal outcome associated with 
an undiagnosed CPF, and the second case illustrates the 
benefit of early detection of a CPF to prevent further 
complications. 
Primary cardiac tumors are very rare and have an 
approximate prevalence of 0.02% based on autopsy 
studies[1]. Myxomas were reported to be the most com-
mon, and CPFs stand second[2]. Gowda et al[3] used the 
term “papillary fibroelastoma” for the first time in a case 
report of myocardial infarction in the absence of coronary 
atherosclerosis. 
CPFs, the most common cardiac valvular tumors, are 
benign endocardial papillomas, with highest prevalence 
in the 6th to 8th decade of life[3,4]. CPFs are predominantly 
valvular with 80% arising from the valvular endocardium. 
The aortic valve is the most commonly involved with 
prevalence between 35% and 63%, followed by the 
mitral valve (9% to 35%), the tricuspid valve (6%-15%), 
and the pulmonary valve (0.5%-8%)[3-5]. In a large single 
center review of highly-selected referral population, CPF 
was more prevalent (0.089% of all echocardiograms) 
than cardiac myxoma[4]. The pathogenesis of CPF is 
unclear. Papillary fibroelastomas have been described 
as neoplasms, hamartomas, organizing thrombi, or post-
traumatic tumors[6]. Some authors believe that CPFs 
represent gaint form of Lambl’s excrescence, evolving 
from a thrombotic phenomenon due to traumatization of 
the endothelial cells at the level of the valves which have 
an increased pressure gradient[5]. Grossly, CPFs have a 
sea anemone appearance with a gelatinous surface and a 
stalk with multiple papillary projections[5]. Microscopically, 
CPFs are avascular and are composed of collagen, elastic, 
and reticulin[5].
Most patients with CPFs are asymptomatic and 
these are incidental findings during echocardiography, 
cardiac surgery, or autopsies[3]. However, the past 
three decades have witnessed reported cases with 
life-threatening cardiac and neurological symptoms, 
including TIA, angina, syncope, stroke, blindness, 
myocardial infarction and sudden death, heart failure, 
among many others. Cerebrovascular events are the 
most common presenting symptom in symptomatic 
patients[4]. In their meta-analysis of 725 CPF cases, 
Gowda et al[3] postulated that tumor mobility was 
the only independent predictor of CPF related death 
or nonfatal embolization. However, in the study by 
Tamin et al[4] echocardiographic characteristics of CPFs 
(size, location, and mobility) were not significantly 
associated with a cerebrovascular accident. CPFs can 
cause symptoms by embolization of either the tumor 
A B
Figure 2  Microscopic photograph of the cardiac papillary fibroelastoma. A: Histological section of the mass shows benign papillary lesion comprised of a single 
layer of endocardial cells overlies a thin layer of mucopolysaccharide matrix and underlying, almost acellular, avascular stroma composed predominantly of elastic 
















Figure 3  Transthoracic echocardiogram showing a cardiac papillary 
fibroelastoma on the aortic valve (marked).
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fragments or a thrombus that has formed on the 
surface of the tumor. This mechanism can explain the 
TIA symptoms in our second case. Direct obstruction by 
the tumor mass resulting in acute myocardial infarction 
can also occur, as in our first case. Our first patient had 
a NSTEMI prior to this admission with non-obstructive 
CAD on prior cardiac catheterization. Autopsy revealed 
an old inferior wall infarct and non-obstructive CAD. 
These findings suggest that the aortic valve CPF was 
causing intermittent obstruction of the right coronary 
ostium resulting in recurrent myocardial infarction and 
subsequent heart failure.
The advent of higher-resolution imaging especially TEE 
facilitates rapid ante-mortem diagnosis in symptomatic 
patients. Currently, depending on symptoms and tumor 
mobility either surgical resection or anticoagulation/
antiplatelet agents are offered to patients. Based on 
available data, surgical resection is strongly recom-
mended in symptomatic patients to prevent further 
cardiovascular or embolic events[3,7]. This was the rationale 
for surgical resection of the CPF in our second patient. 
She had a mobile, pedunculated fibroelastoma on her 
aortic valve causing a TIA (Figure 3). Curative surgical 
resection was done to prevent further complications. 
In asymptomatic patients, there is a debate between 
anticoagulation vs surgical excision. Increased cerebrova-
scular accidents and mortality were observed in patients 
with echocardiographically suspected CPF who did not 
undergo surgical removal[4]. Ikegami et al[7] recommend 
surgical excision in asymptomatic patients with incidental 
CPF finding taking into account the friability, mobility and 
location of the CPF. Literature suggests that successful 
complete resection of CPF is curative with an excellent 
long-term prognosis and a lower stroke risk[3,4].
Given the potential to cause fatal outcomes and the 
availability of successful therapies, CPF should be a diag-
nostic consideration in elderly patients with myocardial 
infarction with normal coronaries or non-obstructive CAD 
after other potential causes of myocardial injury and other 
confounding diagnoses have been ruled out. Diagnostic 
evaluation begins with a TTE, but it is advisable to further 
evaluate with TEE when clinical suspicion for CPF is high, 
as TTE can miss a third of CPF’s evident on a TEE[4]. It must 
be noted that the TTE of our first patient did not reveal a 
CPF. Surgical resection should be offered for symptomatic 
patients and also to asymptomatic patients with high risk 
CPFs. Close monitoring and follow-up is recommended if 
medical management is pursued. Randomized studies 
are needed to make valid recommendations as most of 
the available studies are single center experiences.
COMMENTS
Case characteristics 
Case 1: A 64-year-old man with sudden cardiac arrest; Case 2: A 53-year-old 
female with sudden onset tingling and numbness on her left side of her face, 
mouth, upper and lower extremities.
Clinical diagnosis 
Case 1: Acute myocardial infarction leading to sudden cardiac arrest; Case 2: 
Acute cerebrovascular event/transient ischemic attack (TIA). 
Differential diagnosis 
Case 1: Coronary thromboembolism from atherosclerosis, acute blood loss 
anemia causing cardiac demand ischemia, coronary occlusion secondary to 
vasculitis/arteritis, aortic dissection, with retrograde involvement of the coronary 
arteries, coronary artery emboli, secondary to cholesterol, air, or the products 
of sepsis, drugs (cocaine, etc.); Case 2: Endocarditis, cardiac myxoma, cardiac 
papillary fibroelastomas (CPFs), organized thrombus, valvular lipoma, etc.
Laboratory diagnosis 
Case 1: Acute myocardial infarction; Case: All labs were within normal limits. 
Imaging diagnosis 
Case 2: Transthoracic echocardiography (TTE) showing a cardiac papillary 




Case 2: Complete surgical excision of the CPF. 
Related reports 
Traditionally though to be asymptomatic, the past three decades have 
witnessed reported cases of CPFs with life-threatening cardiac and neurological 
symptoms, including TIA, angina, syncope, stroke, blindness, myocardial 
infarction and sudden death, heart failure, among many others.
Term explanation 
CPFs are benign endocardial papillomas and are the most common cardiac 
valvular tumors. They have the propensity to cause life-threatening cardiac 
and neurologic complications. Surgical resection should be considered in 
symptomatic patients and in asymptomatic patients with high risk feautures.
Experiences and lessons 
TTE can miss a third of the CPFs. A transesophageal echocardiography should 
be considered when there is high clinical suspicion. Early detection is necessary 
to prevent life-threatening cardiac and neurologic complications. Surgical 
resection can be curative.
Peer-review 
The paper is well written.
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